Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We describe therapeutic monoclonal antibodies isolated from human volunteers vaccinated with recombinant adenovirus expressing Ebola virus glycoprotein (EBOV GP) and boosted with modified vaccinia virus Ankara. Among 82 antibodies isolated from peripheral blood B cells, almost half neutralized GP pseudotyped influenza virus. The antibody response was diverse in gene usage and epitope recognition. Although close to germline in sequence, neutralizing antibodies with binding affinities in the nano- to pico-molar range, similar to "affinity matured" antibodies from convalescent donors, were found. They recognized the mucin-like domain, glycan cap, receptor binding region, and the base of the glycoprotein. A cross-reactive cocktail of four antibodies, targeting the latter three non-overlapping epitopes, given on day 3 of EBOV infection, completely protected guinea pigs. This study highlights the value of experimental vaccine trials as a rich source of therapeutic human monoclonal antibodies.

Original publication

DOI

10.1016/j.celrep.2019.03.020

Type

Journal article

Journal

Cell Rep

Publication Date

02/04/2019

Volume

27

Pages

172 - 186.e7

Keywords

E-S-FLU virus, Ebola virus, Ebola virus glycoprotein epitopes, affinity maturation, antibody binding kinetics, guinea pig model, human monoclonal antibodies, immunotherapy, therapeutic antibodies, Adolescent, Adult, Animals, Antibodies, Monoclonal, Antibodies, Neutralizing, Antibodies, Viral, Cells, Cultured, Dogs, Ebola Vaccines, Ebolavirus, Female, Guinea Pigs, HEK293 Cells, Hemorrhagic Fever, Ebola, Humans, Madin Darby Canine Kidney Cells, Male, Middle Aged, Vaccination, Young Adult